| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | extracellular matrix structural constituent conferring tensile strength | COL4A1 COL4A2 COL4A3 COL4A6 COL18A1 COL24A1 COL5A3 COL7A1 COL11A1 COL11A2 | 2.67e-18 | 46 | 43 | 10 | GO:0030020 |
| GeneOntologyMolecularFunction | extracellular matrix structural constituent | COL4A1 COL4A2 COL4A3 COL4A6 COL18A1 COL24A1 COL5A3 COL7A1 COL11A1 COL11A2 | 6.30e-12 | 188 | 43 | 10 | GO:0005201 |
| GeneOntologyMolecularFunction | structural molecule activity | COL4A1 COL4A2 COL4A3 COL4A6 COL18A1 COL24A1 COL5A3 COL7A1 NUP214 COL11A1 COL11A2 BSN EPB41L4B | 2.68e-08 | 891 | 43 | 13 | GO:0005198 |
| GeneOntologyBiologicalProcess | extracellular matrix organization | COL4A1 COL4A2 COL4A3 COL4A6 COL18A1 COL24A1 COL5A3 COL7A1 ZNF469 COL11A1 COL11A2 | 2.24e-10 | 377 | 43 | 11 | GO:0030198 |
| GeneOntologyBiologicalProcess | extracellular structure organization | COL4A1 COL4A2 COL4A3 COL4A6 COL18A1 COL24A1 COL5A3 COL7A1 ZNF469 COL11A1 COL11A2 | 2.30e-10 | 378 | 43 | 11 | GO:0043062 |
| GeneOntologyBiologicalProcess | external encapsulating structure organization | COL4A1 COL4A2 COL4A3 COL4A6 COL18A1 COL24A1 COL5A3 COL7A1 ZNF469 COL11A1 COL11A2 | 2.37e-10 | 379 | 43 | 11 | GO:0045229 |
| GeneOntologyBiologicalProcess | collagen-activated tyrosine kinase receptor signaling pathway | 8.01e-09 | 12 | 43 | 4 | GO:0038063 | |
| GeneOntologyBiologicalProcess | collagen-activated signaling pathway | 4.90e-08 | 18 | 43 | 4 | GO:0038065 | |
| GeneOntologyBiologicalProcess | collagen fibril organization | 1.88e-05 | 76 | 43 | 4 | GO:0030199 | |
| GeneOntologyBiologicalProcess | positive regulation of synaptic transmission, glutamatergic | 9.83e-05 | 43 | 43 | 3 | GO:0051968 | |
| GeneOntologyCellularComponent | collagen trimer | COL4A1 C1QL1 COL4A2 COL4A3 COL4A6 COL18A1 COL24A1 COL5A3 COL7A1 COL11A1 COL11A2 WDR33 | 1.96e-19 | 88 | 43 | 12 | GO:0005581 |
| GeneOntologyCellularComponent | complex of collagen trimers | 3.20e-17 | 21 | 43 | 8 | GO:0098644 | |
| GeneOntologyCellularComponent | collagen type IV trimer | 2.32e-10 | 6 | 43 | 4 | GO:0005587 | |
| GeneOntologyCellularComponent | endoplasmic reticulum lumen | COL4A1 COL4A2 COL4A3 COL4A6 COL18A1 COL24A1 COL5A3 COL7A1 COL11A1 COL11A2 | 1.07e-09 | 332 | 43 | 10 | GO:0005788 |
| GeneOntologyCellularComponent | basement membrane collagen trimer | 1.08e-09 | 8 | 43 | 4 | GO:0098651 | |
| GeneOntologyCellularComponent | network-forming collagen trimer | 1.08e-09 | 8 | 43 | 4 | GO:0098642 | |
| GeneOntologyCellularComponent | collagen network | 1.08e-09 | 8 | 43 | 4 | GO:0098645 | |
| GeneOntologyCellularComponent | collagen-containing extracellular matrix | COL4A1 COL4A2 COL4A3 COL4A6 COL18A1 COL24A1 COL5A3 COL7A1 COL11A1 COL11A2 | 9.12e-08 | 530 | 43 | 10 | GO:0062023 |
| GeneOntologyCellularComponent | basement membrane | 1.78e-07 | 122 | 43 | 6 | GO:0005604 | |
| GeneOntologyCellularComponent | extracellular matrix | COL4A1 COL4A2 COL4A3 COL4A6 COL18A1 COL24A1 COL5A3 COL7A1 COL11A1 COL11A2 | 6.50e-07 | 656 | 43 | 10 | GO:0031012 |
| GeneOntologyCellularComponent | external encapsulating structure | COL4A1 COL4A2 COL4A3 COL4A6 COL18A1 COL24A1 COL5A3 COL7A1 COL11A1 COL11A2 | 6.69e-07 | 658 | 43 | 10 | GO:0030312 |
| GeneOntologyCellularComponent | fibrillar collagen trimer | 1.76e-06 | 12 | 43 | 3 | GO:0005583 | |
| GeneOntologyCellularComponent | banded collagen fibril | 1.76e-06 | 12 | 43 | 3 | GO:0098643 | |
| GeneOntologyCellularComponent | ribbon synapse | 3.86e-05 | 32 | 43 | 3 | GO:0097470 | |
| GeneOntologyCellularComponent | collagen type XI trimer | 4.12e-05 | 5 | 43 | 2 | GO:0005592 | |
| GeneOntologyCellularComponent | neuron to neuron synapse | 8.70e-05 | 523 | 43 | 7 | GO:0098984 | |
| GeneOntologyCellularComponent | asymmetric synapse | 4.08e-04 | 477 | 43 | 6 | GO:0032279 | |
| GeneOntologyCellularComponent | postsynaptic specialization | 5.39e-04 | 503 | 43 | 6 | GO:0099572 | |
| GeneOntologyCellularComponent | postsynaptic specialization membrane | 7.63e-04 | 201 | 43 | 4 | GO:0099634 | |
| GeneOntologyCellularComponent | dopaminergic synapse | 9.30e-04 | 22 | 43 | 2 | GO:0098691 | |
| GeneOntologyCellularComponent | presynaptic active zone cytoplasmic component | 1.02e-03 | 23 | 43 | 2 | GO:0098831 | |
| GeneOntologyCellularComponent | excitatory synapse | 1.39e-03 | 107 | 43 | 3 | GO:0060076 | |
| GeneOntologyCellularComponent | inhibitory synapse | 1.85e-03 | 31 | 43 | 2 | GO:0060077 | |
| GeneOntologyCellularComponent | postsynaptic density | 2.24e-03 | 451 | 43 | 5 | GO:0014069 | |
| GeneOntologyCellularComponent | supramolecular polymer | 2.59e-03 | 1187 | 43 | 8 | GO:0099081 | |
| GeneOntologyCellularComponent | presynaptic active zone | 3.04e-03 | 141 | 43 | 3 | GO:0048786 | |
| GeneOntologyCellularComponent | cell cortex region | 3.87e-03 | 45 | 43 | 2 | GO:0099738 | |
| GeneOntologyCellularComponent | Schaffer collateral - CA1 synapse | 3.97e-03 | 155 | 43 | 3 | GO:0098685 | |
| GeneOntologyCellularComponent | postsynaptic density membrane | 4.12e-03 | 157 | 43 | 3 | GO:0098839 | |
| GeneOntologyCellularComponent | postsynapse | 4.41e-03 | 1018 | 43 | 7 | GO:0098794 | |
| GeneOntologyCellularComponent | GABA-ergic synapse | 4.65e-03 | 164 | 43 | 3 | GO:0098982 | |
| GeneOntologyCellularComponent | synaptic membrane | 6.66e-03 | 583 | 43 | 5 | GO:0097060 | |
| GeneOntologyCellularComponent | transcription regulator complex | 7.29e-03 | 596 | 43 | 5 | GO:0005667 | |
| GeneOntologyCellularComponent | axon | 9.35e-03 | 891 | 43 | 6 | GO:0030424 | |
| GeneOntologyCellularComponent | postsynaptic membrane | 9.44e-03 | 405 | 43 | 4 | GO:0045211 | |
| HumanPheno | Retinal detachment | 2.01e-06 | 118 | 18 | 6 | HP:0000541 | |
| HumanPheno | Myopia | COL4A1 COL4A3 MPLKIP COL4A6 COL18A1 ZNF469 COL11A1 COL11A2 IQSEC2 | 6.75e-06 | 447 | 18 | 9 | HP:0000545 |
| HumanPheno | Vitreoretinopathy | 5.47e-05 | 22 | 18 | 3 | HP:0007773 | |
| HumanPheno | Abnormal corneal epithelium morphology | 7.07e-05 | 132 | 18 | 5 | HP:0011495 | |
| HumanPheno | Degenerative vitreoretinopathy | 1.17e-04 | 5 | 18 | 2 | HP:0007964 | |
| MousePheno | subarachnoid hemorrhage | 4.08e-05 | 4 | 37 | 2 | MP:0031109 | |
| MousePheno | buphthalmos | 4.08e-05 | 4 | 37 | 2 | MP:0009274 | |
| MousePheno | absent NK T cells | 6.78e-05 | 5 | 37 | 2 | MP:0008041 | |
| MousePheno | anterior polar cataract | 6.78e-05 | 5 | 37 | 2 | MP:0010259 | |
| MousePheno | polar cataract | 1.02e-04 | 6 | 37 | 2 | MP:0010258 | |
| MousePheno | podocyte foot process effacement | 1.35e-04 | 38 | 37 | 3 | MP:0008140 | |
| MousePheno | irregularly shaped pupil | 1.46e-04 | 39 | 37 | 3 | MP:0001319 | |
| MousePheno | abnormal basement membrane morphology | 1.58e-04 | 40 | 37 | 3 | MP:0004272 | |
| MousePheno | macrophthalmia | 1.89e-04 | 8 | 37 | 2 | MP:0001296 | |
| MousePheno | abnormal synovial joint morphology | 3.11e-04 | 124 | 37 | 4 | MP:0030804 | |
| Domain | Collagen | COL4A1 C1QL1 COL4A2 COL4A3 COL4A6 COL18A1 COL24A1 COL5A3 COL7A1 COL11A1 COL11A2 WDR33 | 4.81e-19 | 85 | 43 | 12 | PF01391 |
| Domain | Collagen | COL4A1 C1QL1 COL4A2 COL4A3 COL4A6 COL18A1 COL24A1 COL5A3 COL7A1 COL11A1 COL11A2 WDR33 | 4.81e-19 | 85 | 43 | 12 | IPR008160 |
| Domain | C4 | 3.64e-10 | 6 | 43 | 4 | SM00111 | |
| Domain | - | 3.64e-10 | 6 | 43 | 4 | 2.170.240.10 | |
| Domain | Collagen_VI_NC | 3.64e-10 | 6 | 43 | 4 | IPR001442 | |
| Domain | NC1_IV | 3.64e-10 | 6 | 43 | 4 | PS51403 | |
| Domain | C4 | 3.64e-10 | 6 | 43 | 4 | PF01413 | |
| Domain | TSPN | 1.66e-09 | 23 | 43 | 5 | SM00210 | |
| Domain | NC1_FIB | 7.94e-09 | 11 | 43 | 4 | PS51461 | |
| Domain | Fib_collagen_C | 7.94e-09 | 11 | 43 | 4 | IPR000885 | |
| Domain | Fib_collagen_C | 7.94e-09 | 11 | 43 | 4 | PD002078 | |
| Domain | COLFI | 7.94e-09 | 11 | 43 | 4 | SM00038 | |
| Domain | COLFI | 7.94e-09 | 11 | 43 | 4 | PF01410 | |
| Domain | Laminin_G | 2.13e-07 | 58 | 43 | 5 | IPR001791 | |
| Domain | Laminin_G_2 | 2.10e-06 | 40 | 43 | 4 | PF02210 | |
| Domain | LamG | 3.09e-06 | 44 | 43 | 4 | SM00282 | |
| Domain | CTDL_fold | 4.55e-06 | 107 | 43 | 5 | IPR016187 | |
| Domain | - | 6.66e-05 | 95 | 43 | 4 | 2.60.120.200 | |
| Domain | ConA-like_dom | 1.42e-04 | 219 | 43 | 5 | IPR013320 | |
| Domain | FRI | 9.58e-04 | 20 | 43 | 2 | SM00063 | |
| Domain | - | 1.06e-03 | 21 | 43 | 2 | 1.10.2000.10 | |
| Domain | Frizzled_dom | 1.38e-03 | 24 | 43 | 2 | IPR020067 | |
| Domain | FZ | 1.38e-03 | 24 | 43 | 2 | PS50038 | |
| Domain | Fz | 1.38e-03 | 24 | 43 | 2 | PF01392 | |
| Domain | BTB | 3.39e-03 | 131 | 43 | 3 | PF00651 | |
| Domain | BTB | 5.92e-03 | 160 | 43 | 3 | PS50097 | |
| Domain | BTB | 8.19e-03 | 180 | 43 | 3 | SM00225 | |
| Domain | BTB/POZ_dom | 8.82e-03 | 185 | 43 | 3 | IPR000210 | |
| Domain | SKP1/BTB/POZ | 9.35e-03 | 189 | 43 | 3 | IPR011333 | |
| Domain | RRM_1 | 1.21e-02 | 208 | 43 | 3 | PF00076 | |
| Pathway | REACTOME_COLLAGEN_CHAIN_TRIMERIZATION | COL4A1 COL4A2 COL4A3 COL4A6 COL18A1 COL24A1 COL5A3 COL7A1 COL11A1 COL11A2 | 3.63e-18 | 44 | 34 | 10 | M27812 |
| Pathway | REACTOME_ASSEMBLY_OF_COLLAGEN_FIBRILS_AND_OTHER_MULTIMERIC_STRUCTURES | COL4A1 COL4A2 COL4A3 COL4A6 COL18A1 COL24A1 COL5A3 COL7A1 COL11A1 COL11A2 | 1.28e-16 | 61 | 34 | 10 | M27103 |
| Pathway | REACTOME_COLLAGEN_CHAIN_TRIMERIZATION | COL4A1 COL4A2 COL4A3 COL4A6 COL18A1 COL5A3 COL7A1 COL11A1 COL11A2 | 2.89e-16 | 41 | 34 | 9 | MM15538 |
| Pathway | REACTOME_COLLAGEN_BIOSYNTHESIS_AND_MODIFYING_ENZYMES | COL4A1 COL4A2 COL4A3 COL4A6 COL18A1 COL24A1 COL5A3 COL7A1 COL11A1 COL11A2 | 3.50e-16 | 67 | 34 | 10 | M26999 |
| Pathway | REACTOME_ASSEMBLY_OF_COLLAGEN_FIBRILS_AND_OTHER_MULTIMERIC_STRUCTURES | COL4A1 COL4A2 COL4A3 COL4A6 COL18A1 COL5A3 COL7A1 COL11A1 COL11A2 | 2.04e-15 | 50 | 34 | 9 | MM14796 |
| Pathway | REACTOME_COLLAGEN_DEGRADATION | COL4A1 COL4A2 COL4A3 COL4A6 COL18A1 COL5A3 COL7A1 COL11A1 COL11A2 | 3.58e-15 | 53 | 34 | 9 | MM14566 |
| Pathway | REACTOME_COLLAGEN_FORMATION | COL4A1 COL4A2 COL4A3 COL4A6 COL18A1 COL24A1 COL5A3 COL7A1 COL11A1 COL11A2 | 7.78e-15 | 90 | 34 | 10 | M631 |
| Pathway | REACTOME_COLLAGEN_BIOSYNTHESIS_AND_MODIFYING_ENZYMES | COL4A1 COL4A2 COL4A3 COL4A6 COL18A1 COL5A3 COL7A1 COL11A1 COL11A2 | 1.38e-14 | 61 | 34 | 9 | MM14637 |
| Pathway | REACTOME_COLLAGEN_DEGRADATION | COL4A1 COL4A2 COL4A3 COL4A6 COL18A1 COL5A3 COL7A1 COL11A1 COL11A2 | 2.19e-14 | 64 | 34 | 9 | M26953 |
| Pathway | REACTOME_COLLAGEN_FORMATION | COL4A1 COL4A2 COL4A3 COL4A6 COL18A1 COL5A3 COL7A1 COL11A1 COL11A2 | 1.11e-13 | 76 | 34 | 9 | MM14573 |
| Pathway | REACTOME_NON_INTEGRIN_MEMBRANE_ECM_INTERACTIONS | 7.92e-13 | 32 | 34 | 7 | MM14924 | |
| Pathway | REACTOME_DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX | COL4A1 COL4A2 COL4A3 COL4A6 COL18A1 COL5A3 COL7A1 COL11A1 COL11A2 | 4.75e-12 | 114 | 34 | 9 | MM14571 |
| Pathway | REACTOME_DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX | COL4A1 COL4A2 COL4A3 COL4A6 COL18A1 COL5A3 COL7A1 COL11A1 COL11A2 | 3.08e-11 | 140 | 34 | 9 | M587 |
| Pathway | REACTOME_LAMININ_INTERACTIONS | 7.04e-11 | 30 | 34 | 6 | M27216 | |
| Pathway | REACTOME_NON_INTEGRIN_MEMBRANE_ECM_INTERACTIONS | 7.67e-11 | 59 | 34 | 7 | M27218 | |
| Pathway | PID_INTEGRIN1_PATHWAY | 1.73e-10 | 66 | 34 | 7 | M18 | |
| Pathway | REACTOME_ANCHORING_FIBRIL_FORMATION | 1.77e-10 | 15 | 34 | 5 | M27161 | |
| Pathway | REACTOME_INTEGRIN_CELL_SURFACE_INTERACTIONS | 4.78e-10 | 76 | 34 | 7 | MM14867 | |
| Pathway | REACTOME_INTEGRIN_CELL_SURFACE_INTERACTIONS | 1.06e-09 | 85 | 34 | 7 | M16441 | |
| Pathway | PID_SYNDECAN_1_PATHWAY | 1.08e-09 | 46 | 34 | 6 | M198 | |
| Pathway | REACTOME_EXTRACELLULAR_MATRIX_ORGANIZATION | COL4A1 COL4A2 COL4A3 COL4A6 COL18A1 COL24A1 COL5A3 COL7A1 COL11A1 COL11A2 | 1.37e-09 | 300 | 34 | 10 | M610 |
| Pathway | BIOCARTA_NPP1_PATHWAY | 5.86e-09 | 10 | 34 | 4 | M22040 | |
| Pathway | BIOCARTA_NPP1_PATHWAY | 5.86e-09 | 10 | 34 | 4 | MM1560 | |
| Pathway | REACTOME_EXTRACELLULAR_MATRIX_ORGANIZATION | COL4A1 COL4A2 COL4A3 COL4A6 COL18A1 COL5A3 COL7A1 COL11A1 COL11A2 | 7.05e-09 | 258 | 34 | 9 | MM14572 |
| Pathway | BIOCARTA_VITCB_PATHWAY | 9.19e-09 | 11 | 34 | 4 | M15422 | |
| Pathway | BIOCARTA_VITCB_PATHWAY | 1.38e-08 | 12 | 34 | 4 | MM1526 | |
| Pathway | BIOCARTA_ACE2_PATHWAY | 1.99e-08 | 13 | 34 | 4 | MM1347 | |
| Pathway | BIOCARTA_ACE2_PATHWAY | 1.99e-08 | 13 | 34 | 4 | M12950 | |
| Pathway | PID_AVB3_INTEGRIN_PATHWAY | 2.04e-08 | 74 | 34 | 6 | M160 | |
| Pathway | BIOCARTA_PLATELETAPP_PATHWAY | 2.77e-08 | 14 | 34 | 4 | MM1458 | |
| Pathway | BIOCARTA_PLATELETAPP_PATHWAY | 2.77e-08 | 14 | 34 | 4 | M6487 | |
| Pathway | REACTOME_LAMININ_INTERACTIONS | 3.78e-08 | 15 | 34 | 4 | MM14922 | |
| Pathway | KEGG_ECM_RECEPTOR_INTERACTION | 4.40e-08 | 84 | 34 | 6 | M7098 | |
| Pathway | REACTOME_CROSSLINKING_OF_COLLAGEN_FIBRILS | 8.42e-08 | 18 | 34 | 4 | M27164 | |
| Pathway | REACTOME_CROSSLINKING_OF_COLLAGEN_FIBRILS | 8.42e-08 | 18 | 34 | 4 | MM14882 | |
| Pathway | BIOCARTA_AMI_PATHWAY | 1.33e-07 | 20 | 34 | 4 | M15394 | |
| Pathway | REACTOME_NCAM1_INTERACTIONS | 1.33e-07 | 20 | 34 | 4 | MM15061 | |
| Pathway | BIOCARTA_INTRINSIC_PATHWAY | 2.42e-07 | 23 | 34 | 4 | M15997 | |
| Pathway | BIOCARTA_INTRINSIC_PATHWAY | 2.42e-07 | 23 | 34 | 4 | MM1427 | |
| Pathway | REACTOME_MET_ACTIVATES_PTK2_SIGNALING | 7.39e-07 | 30 | 34 | 4 | M27772 | |
| Pathway | REACTOME_ECM_PROTEOGLYCANS | 9.82e-07 | 76 | 34 | 5 | M27219 | |
| Pathway | REACTOME_NCAM_SIGNALING_FOR_NEURITE_OUT_GROWTH | 1.96e-06 | 38 | 34 | 4 | MM14969 | |
| Pathway | REACTOME_MET_PROMOTES_CELL_MOTILITY | 2.68e-06 | 41 | 34 | 4 | M27778 | |
| Pathway | REACTOME_NCAM1_INTERACTIONS | 2.96e-06 | 42 | 34 | 4 | M7169 | |
| Pathway | WP_FOCAL_ADHESION | 4.97e-06 | 187 | 34 | 6 | MM15913 | |
| Pathway | KEGG_FOCAL_ADHESION | 7.10e-06 | 199 | 34 | 6 | M7253 | |
| Pathway | REACTOME_SIGNALING_BY_PDGF | 1.02e-05 | 57 | 34 | 4 | MM14713 | |
| Pathway | REACTOME_SIGNALING_BY_PDGF | 1.09e-05 | 58 | 34 | 4 | M2049 | |
| Pathway | REACTOME_MET_ACTIVATES_PTK2_SIGNALING | 1.21e-05 | 19 | 34 | 3 | MM15512 | |
| Pathway | REACTOME_NCAM_SIGNALING_FOR_NEURITE_OUT_GROWTH | 1.52e-05 | 63 | 34 | 4 | M11187 | |
| Pathway | REACTOME_SIGNALING_BY_RECEPTOR_TYROSINE_KINASES | 2.97e-05 | 532 | 34 | 8 | M27870 | |
| Pathway | REACTOME_SIGNALING_BY_MET | 3.73e-05 | 79 | 34 | 4 | M27643 | |
| Pathway | WP_EPITHELIAL_TO_MESENCHYMAL_TRANSITION_IN_COLORECTAL_CANCER | 3.89e-05 | 161 | 34 | 5 | M39770 | |
| Pathway | REACTOME_MET_PROMOTES_CELL_MOTILITY | 4.98e-05 | 30 | 34 | 3 | MM15517 | |
| Pathway | WP_FOCAL_ADHESION_PI3KAKTMTORSIGNALING | 7.46e-05 | 302 | 34 | 6 | M39719 | |
| Pathway | WP_SMALL_CELL_LUNG_CANCER | 8.01e-05 | 96 | 34 | 4 | M39834 | |
| Pathway | WP_FOCAL_ADHESION_PI3KAKTMTOR_SIGNALING_PATHWAY | 1.14e-04 | 326 | 34 | 6 | MM15917 | |
| Pathway | WP_MIRNA_TARGETS_IN_ECM_AND_MEMBRANE_RECEPTORS | 1.48e-04 | 43 | 34 | 3 | M39565 | |
| Pathway | PID_INTEGRIN3_PATHWAY | 1.48e-04 | 43 | 34 | 3 | M53 | |
| Pathway | WP_PREIMPLANTATION_EMBRYO | 3.80e-04 | 59 | 34 | 3 | M39579 | |
| Pathway | REACTOME_SIGNALING_BY_RECEPTOR_TYROSINE_KINASES | 4.36e-04 | 418 | 34 | 6 | MM15587 | |
| Pathway | REACTOME_SIGNALING_BY_MET | 5.53e-04 | 67 | 34 | 3 | MM15345 | |
| Pathway | WP_PLEURAL_MESOTHELIOMA | 5.65e-04 | 439 | 34 | 6 | M42563 | |
| Pathway | REACTOME_SCAVENGING_BY_CLASS_A_RECEPTORS | 9.41e-04 | 19 | 34 | 2 | M27221 | |
| Pathway | KEGG_SMALL_CELL_LUNG_CANCER | 1.07e-03 | 84 | 34 | 3 | M3228 | |
| Pathway | WP_FOCAL_ADHESION | 1.28e-03 | 199 | 34 | 4 | M39402 | |
| Pathway | WP_DYSREGULATED_MIRNA_TARGETING_IN_INSULINPI3KAKT_SIGNALING | 2.05e-03 | 28 | 34 | 2 | MM15957 | |
| Pathway | REACTOME_NERVOUS_SYSTEM_DEVELOPMENT | 3.44e-03 | 261 | 34 | 4 | MM15676 | |
| Pathway | REACTOME_TRANSPORT_OF_MATURE_MRNAS_DERIVED_FROM_INTRONLESS_TRANSCRIPTS | 4.79e-03 | 43 | 34 | 2 | M26975 | |
| Pathway | PID_NFAT_TFPATHWAY | 5.24e-03 | 45 | 34 | 2 | M60 | |
| Pathway | REACTOME_DEVELOPMENTAL_BIOLOGY | 5.63e-03 | 1432 | 34 | 9 | M509 | |
| Pathway | REACTOME_SUMOYLATION_OF_RNA_BINDING_PROTEINS | 5.70e-03 | 47 | 34 | 2 | M27395 | |
| Pathway | REACTOME_TRANSPORT_OF_MATURE_MRNAS_DERIVED_FROM_INTRONLESS_TRANSCRIPTS | 6.43e-03 | 50 | 34 | 2 | MM14610 | |
| Pathway | REACTOME_DEVELOPMENTAL_BIOLOGY | 6.65e-03 | 502 | 34 | 5 | MM14537 | |
| Pathway | WP_CANCER_PATHWAYS | 6.93e-03 | 507 | 34 | 5 | M48302 | |
| Pathway | KEGG_PATHWAYS_IN_CANCER | 7.46e-03 | 325 | 34 | 4 | M12868 | |
| Pubmed | Characterization of the Extracellular Matrix of Normal and Diseased Tissues Using Proteomics. | COL4A1 COL4A2 COL4A3 COL4A6 COL18A1 COL24A1 COL5A3 COL7A1 COL11A1 COL11A2 | 9.51e-16 | 135 | 43 | 10 | 28675934 |
| Pubmed | COL4A1 COL4A2 COL4A3 COL4A6 COL18A1 COL24A1 COL5A3 COL7A1 COL11A1 COL11A2 | 1.33e-14 | 175 | 43 | 10 | 28071719 | |
| Pubmed | Proteomic characterization of human multiple myeloma bone marrow extracellular matrix. | 1.24e-12 | 62 | 43 | 7 | 28344315 | |
| Pubmed | Stimulation of extracellular matrix components in the normal brain by invading glioma cells. | 3.03e-11 | 6 | 43 | 4 | 9506531 | |
| Pubmed | 3.03e-11 | 6 | 43 | 4 | 2426947 | ||
| Pubmed | Angiogenesis and collagen type IV expression in different endothelial cell culture systems. | 3.03e-11 | 6 | 43 | 4 | 23551189 | |
| Pubmed | Monoclonal antibody to human basement membrane collagen type IV. | 3.03e-11 | 6 | 43 | 4 | 6811420 | |
| Pubmed | Immunolocalization of collagen types, laminin and fibronectin in the normal human pancreas. | 3.03e-11 | 6 | 43 | 4 | 6389236 | |
| Pubmed | 3.03e-11 | 6 | 43 | 4 | 12225806 | ||
| Pubmed | Insertional mutation of the collagen genes Col4a3 and Col4a4 in a mouse model of Alport syndrome. | 3.03e-11 | 6 | 43 | 4 | 10534397 | |
| Pubmed | A tumor derived motility factor that stimulates cell migration on extracellular matrix. | 3.03e-11 | 6 | 43 | 4 | 9673377 | |
| Pubmed | 3.03e-11 | 6 | 43 | 4 | 11732842 | ||
| Pubmed | Developmental distribution of collagen IV isoforms and relevance to ocular diseases. | 3.03e-11 | 6 | 43 | 4 | 19275937 | |
| Pubmed | 3.03e-11 | 6 | 43 | 4 | 6988303 | ||
| Pubmed | 7.07e-11 | 7 | 43 | 4 | 11711546 | ||
| Pubmed | Regulation of protease nexin-1 target protease specificity by collagen type IV. | 7.07e-11 | 7 | 43 | 4 | 8006028 | |
| Pubmed | 7.07e-11 | 7 | 43 | 4 | 10416788 | ||
| Pubmed | 7.07e-11 | 7 | 43 | 4 | 1724753 | ||
| Pubmed | 1.41e-10 | 8 | 43 | 4 | 3997552 | ||
| Pubmed | 1.41e-10 | 8 | 43 | 4 | 29422532 | ||
| Pubmed | 1.41e-10 | 8 | 43 | 4 | 1377218 | ||
| Pubmed | 1.41e-10 | 8 | 43 | 4 | 10382266 | ||
| Pubmed | Discoidin domain receptor 1 functions in axon extension of cerebellar granule neurons. | 1.41e-10 | 8 | 43 | 4 | 10970885 | |
| Pubmed | 2.54e-10 | 9 | 43 | 4 | 9878537 | ||
| Pubmed | 2.54e-10 | 9 | 43 | 4 | 12101409 | ||
| Pubmed | 4.23e-10 | 10 | 43 | 4 | 9136074 | ||
| Pubmed | Transcriptome-based systematic identification of extracellular matrix proteins. | 6.45e-10 | 79 | 43 | 6 | 18757743 | |
| Pubmed | 6.64e-10 | 11 | 43 | 4 | 14998921 | ||
| Pubmed | Binding of mouse and human fibulin-2 to extracellular matrix ligands. | 6.64e-10 | 11 | 43 | 4 | 7500359 | |
| Pubmed | 7.84e-10 | 153 | 43 | 7 | 25037231 | ||
| Pubmed | Matrilin-2 interacts with itself and with other extracellular matrix proteins. | 9.95e-10 | 12 | 43 | 4 | 12180907 | |
| Pubmed | Basement membrane fragility underlies embryonic lethality in fukutin-null mice. | 9.95e-10 | 12 | 43 | 4 | 15837576 | |
| Pubmed | 9.95e-10 | 12 | 43 | 4 | 16024816 | ||
| Pubmed | 1.27e-09 | 39 | 43 | 5 | 33580754 | ||
| Pubmed | 1.45e-09 | 167 | 43 | 7 | 22159717 | ||
| Pubmed | Collagen mRNA levels changes during colorectal cancer carcinogenesis. | 1.76e-09 | 3 | 43 | 3 | 19422682 | |
| Pubmed | 1.76e-09 | 3 | 43 | 3 | 3025878 | ||
| Pubmed | 2.01e-09 | 14 | 43 | 4 | 12878203 | ||
| Pubmed | 3.65e-09 | 16 | 43 | 4 | 15878328 | ||
| Pubmed | Nature and the multiple functions of the 67-kD elastin-/laminin binding protein. | 7.04e-09 | 4 | 43 | 3 | 7827955 | |
| Pubmed | 7.09e-09 | 210 | 43 | 7 | 16537572 | ||
| Pubmed | 7.74e-09 | 19 | 43 | 4 | 15689378 | ||
| Pubmed | 1.19e-08 | 21 | 43 | 4 | 23325811 | ||
| Pubmed | 1.19e-08 | 21 | 43 | 4 | 27856617 | ||
| Pubmed | 1.76e-08 | 5 | 43 | 3 | 9409248 | ||
| Pubmed | 2.97e-08 | 26 | 43 | 4 | 24742657 | ||
| Pubmed | 3.51e-08 | 6 | 43 | 3 | 7495302 | ||
| Pubmed | 3.51e-08 | 6 | 43 | 3 | 10722718 | ||
| Pubmed | 3.51e-08 | 6 | 43 | 3 | 16041630 | ||
| Pubmed | 6.14e-08 | 7 | 43 | 3 | 10639489 | ||
| Pubmed | Hypoplastic basement membrane of the lens anlage in the inheritable lens aplastic mouse (lap mouse). | 6.14e-08 | 7 | 43 | 3 | 10716744 | |
| Pubmed | 6.14e-08 | 7 | 43 | 3 | 7521231 | ||
| Pubmed | 6.14e-08 | 7 | 43 | 3 | 17418794 | ||
| Pubmed | 6.22e-08 | 31 | 43 | 4 | 22925884 | ||
| Pubmed | The pro-alpha2(XI) collagen gene is expressed in odontoblasts. | 9.82e-08 | 8 | 43 | 3 | 20059976 | |
| Pubmed | Molecular properties of wild-type and mutant betaIG-H3 proteins. | 9.82e-08 | 8 | 43 | 3 | 11867580 | |
| Pubmed | 1.47e-07 | 9 | 43 | 3 | 8562707 | ||
| Pubmed | 1.47e-07 | 9 | 43 | 3 | 10880400 | ||
| Pubmed | 1.47e-07 | 9 | 43 | 3 | 8995276 | ||
| Pubmed | 1.79e-07 | 40 | 43 | 4 | 27068110 | ||
| Pubmed | 2.10e-07 | 10 | 43 | 3 | 9415455 | ||
| Pubmed | Interaction of hydroxylated collagen IV with the von hippel-lindau tumor suppressor. | 2.88e-07 | 11 | 43 | 3 | 17339318 | |
| Pubmed | Sensory ataxia and muscle spindle agenesis in mice lacking the transcription factor Egr3. | 2.88e-07 | 11 | 43 | 3 | 9731539 | |
| Pubmed | 3.84e-07 | 12 | 43 | 3 | 26794322 | ||
| Pubmed | 3.84e-07 | 12 | 43 | 3 | 8918877 | ||
| Pubmed | Basal lamina molecules are concentrated in myogenic regions of the mouse limb bud. | 4.99e-07 | 13 | 43 | 3 | 9833687 | |
| Pubmed | 6.35e-07 | 14 | 43 | 3 | 19542224 | ||
| Pubmed | 6.35e-07 | 14 | 43 | 3 | 19858219 | ||
| Pubmed | 7.93e-07 | 15 | 43 | 3 | 10625553 | ||
| Pubmed | 7.93e-07 | 15 | 43 | 3 | 9264260 | ||
| Pubmed | Inhibition of distal lung morphogenesis in Nkx2.1(-/-) embryos. | 7.93e-07 | 15 | 43 | 3 | 10706142 | |
| Pubmed | GATA2 ZBTB9 ZBTB10 PRR12 JUNB NUP214 RBM12 PYGO2 SSBP3 WDR33 RING1 | 9.27e-07 | 1429 | 43 | 11 | 35140242 | |
| Pubmed | 1.22e-06 | 64 | 43 | 4 | 22261194 | ||
| Pubmed | 1.26e-06 | 152 | 43 | 5 | 38360978 | ||
| Pubmed | 1.42e-06 | 18 | 43 | 3 | 9160753 | ||
| Pubmed | 1.49e-06 | 2 | 43 | 2 | 17179069 | ||
| Pubmed | 1.49e-06 | 2 | 43 | 2 | 32515830 | ||
| Pubmed | Sequence variants in COL4A1 and COL4A2 genes in Ecuadorian families with keratoconus. | 1.49e-06 | 2 | 43 | 2 | 21527998 | |
| Pubmed | 1.49e-06 | 2 | 43 | 2 | 39216230 | ||
| Pubmed | 1.49e-06 | 2 | 43 | 2 | 24317722 | ||
| Pubmed | 1.49e-06 | 2 | 43 | 2 | 31331924 | ||
| Pubmed | 1.49e-06 | 2 | 43 | 2 | 33348901 | ||
| Pubmed | 1.49e-06 | 2 | 43 | 2 | 11780999 | ||
| Pubmed | 1.49e-06 | 2 | 43 | 2 | 30351356 | ||
| Pubmed | Mutations in Col4a1 cause perinatal cerebral hemorrhage and porencephaly. | 1.49e-06 | 2 | 43 | 2 | 15905400 | |
| Pubmed | 1.49e-06 | 2 | 43 | 2 | 24203695 | ||
| Pubmed | 1.49e-06 | 2 | 43 | 2 | 3198626 | ||
| Pubmed | Intracerebral hemorrhage in a neonate with an intragenic COL4A2 duplication. | 1.49e-06 | 2 | 43 | 2 | 33247988 | |
| Pubmed | 1.49e-06 | 2 | 43 | 2 | 32413593 | ||
| Pubmed | 1.49e-06 | 2 | 43 | 2 | 26209635 | ||
| Pubmed | Differential in situ expression of alpha2(XI) collagen mRNA isoforms in the developing mouse. | 1.49e-06 | 2 | 43 | 2 | 9560475 | |
| Pubmed | 1.49e-06 | 2 | 43 | 2 | 33148145 | ||
| Pubmed | 1.49e-06 | 2 | 43 | 2 | 2846280 | ||
| Pubmed | 1.49e-06 | 2 | 43 | 2 | 2591970 | ||
| Pubmed | Genotype-phenotype correlations in pathology caused by collagen type IV alpha 1 and 2 mutations. | 1.49e-06 | 2 | 43 | 2 | 27794444 | |
| Pubmed | Do mutations in COL4A1 or COL4A2 cause thin basement membrane nephropathy (TBMN)? | 1.49e-06 | 2 | 43 | 2 | 17216253 | |
| Pubmed | 1.49e-06 | 2 | 43 | 2 | 34735964 | ||
| Pubmed | Immunohistochemical localization of collagen type XI alpha1 and alpha2 chains in human colon tissue. | 1.49e-06 | 2 | 43 | 2 | 18040076 | |
| Pubmed | Neurologic phenotypes associated with COL4A1/2 mutations: Expanding the spectrum of disease. | 1.49e-06 | 2 | 43 | 2 | 30413629 | |
| Pubmed | 1.49e-06 | 2 | 43 | 2 | 34281442 | ||
| Interaction | HABP2 interactions | 5.38e-08 | 18 | 43 | 4 | int:HABP2 | |
| Interaction | LAIR2 interactions | 6.19e-08 | 49 | 43 | 5 | int:LAIR2 | |
| Interaction | OSM interactions | 8.49e-08 | 20 | 43 | 4 | int:OSM | |
| Interaction | FBLN2 interactions | 2.82e-07 | 66 | 43 | 5 | int:FBLN2 | |
| Interaction | MMP9 interactions | 3.05e-07 | 67 | 43 | 5 | int:MMP9 | |
| Interaction | MMP2 interactions | 1.13e-06 | 87 | 43 | 5 | int:MMP2 | |
| Interaction | CD93 interactions | 2.51e-06 | 45 | 43 | 4 | int:CD93 | |
| Interaction | GATA3 interactions | 2.70e-06 | 187 | 43 | 6 | int:GATA3 | |
| Interaction | C1QTNF1 interactions | 3.00e-06 | 47 | 43 | 4 | int:C1QTNF1 | |
| Interaction | COL4A1 interactions | 3.26e-06 | 48 | 43 | 4 | int:COL4A1 | |
| Interaction | SAA1 interactions | 5.26e-06 | 54 | 43 | 4 | int:SAA1 | |
| Interaction | SERPINE2 interactions | 6.09e-06 | 56 | 43 | 4 | int:SERPINE2 | |
| Interaction | THBS1 interactions | 7.30e-06 | 127 | 43 | 5 | int:THBS1 | |
| Interaction | EYA4 interactions | 1.21e-05 | 243 | 43 | 6 | int:EYA4 | |
| Interaction | TGFBI interactions | 2.01e-05 | 25 | 43 | 3 | int:TGFBI | |
| Interaction | BGN interactions | 3.53e-05 | 30 | 43 | 3 | int:BGN | |
| Interaction | SP7 interactions | 4.27e-05 | 304 | 43 | 6 | int:SP7 | |
| Interaction | GATA2 interactions | 6.34e-05 | 199 | 43 | 5 | int:GATA2 | |
| Interaction | C1QTNF9 interactions | 6.68e-05 | 37 | 43 | 3 | int:C1QTNF9 | |
| Interaction | MATN2 interactions | 9.77e-05 | 113 | 43 | 4 | int:MATN2 | |
| Interaction | C1QC interactions | 9.80e-05 | 42 | 43 | 3 | int:C1QC | |
| Interaction | COL8A2 interactions | 9.80e-05 | 42 | 43 | 3 | int:COL8A2 | |
| Interaction | DCN interactions | 1.05e-04 | 43 | 43 | 3 | int:DCN | |
| Interaction | BMP3 interactions | 1.24e-04 | 8 | 43 | 2 | int:BMP3 | |
| Interaction | NUP35 interactions | 2.64e-04 | 424 | 43 | 6 | int:NUP35 | |
| Interaction | DLG4 interactions | 3.59e-04 | 449 | 43 | 6 | int:DLG4 | |
| Interaction | TLX3 interactions | 3.73e-04 | 291 | 43 | 5 | int:TLX3 | |
| Interaction | COLGALT2 interactions | 3.94e-04 | 67 | 43 | 3 | int:COLGALT2 | |
| Interaction | P4HA1 interactions | 4.15e-04 | 298 | 43 | 5 | int:P4HA1 | |
| Interaction | TLX1 interactions | 5.21e-04 | 175 | 43 | 4 | int:TLX1 | |
| Interaction | TEAD1 interactions | 5.32e-04 | 176 | 43 | 4 | int:TEAD1 | |
| Interaction | ALG13 interactions | 6.16e-04 | 183 | 43 | 4 | int:ALG13 | |
| Interaction | PLOD3 interactions | 6.16e-04 | 183 | 43 | 4 | int:PLOD3 | |
| Interaction | LHX3 interactions | 6.41e-04 | 185 | 43 | 4 | int:LHX3 | |
| Interaction | ZBTB16 interactions | 6.68e-04 | 187 | 43 | 4 | int:ZBTB16 | |
| Interaction | KLF5 interactions | 7.81e-04 | 195 | 43 | 4 | int:KLF5 | |
| Interaction | IRF4 interactions | 7.91e-04 | 85 | 43 | 3 | int:IRF4 | |
| Cytoband | 19q13.33 | 1.38e-04 | 106 | 43 | 3 | 19q13.33 | |
| Cytoband | 13q34 | 1.19e-03 | 54 | 43 | 2 | 13q34 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr13q34 | 3.12e-03 | 88 | 43 | 2 | chr13q34 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr19q13 | 4.97e-03 | 1192 | 43 | 5 | chr19q13 | |
| GeneFamily | Collagens | COL4A1 COL4A2 COL4A3 COL4A6 COL18A1 COL24A1 COL5A3 COL7A1 COL11A1 COL11A2 | 1.32e-18 | 46 | 37 | 10 | 490 |
| GeneFamily | Basic leucine zipper proteins|BTB domain containing | 2.57e-03 | 134 | 37 | 3 | 861 | |
| Coexpression | NABA_COLLAGENS | COL4A1 COL4A2 COL4A3 COL4A6 COL18A1 COL24A1 COL5A3 COL7A1 COL11A1 COL11A2 | 8.41e-20 | 43 | 43 | 10 | MM17060 |
| Coexpression | NABA_COLLAGENS | COL4A1 COL4A2 COL4A3 COL4A6 COL18A1 COL24A1 COL5A3 COL7A1 COL11A1 COL11A2 | 1.09e-19 | 44 | 43 | 10 | M3005 |
| Coexpression | NABA_CORE_MATRISOME | COL4A1 COL4A2 COL4A3 COL4A6 COL18A1 COL24A1 COL5A3 COL7A1 COL11A1 COL11A2 | 1.62e-11 | 270 | 43 | 10 | MM17057 |
| Coexpression | NABA_CORE_MATRISOME | COL4A1 COL4A2 COL4A3 COL4A6 COL18A1 COL24A1 COL5A3 COL7A1 COL11A1 COL11A2 | 1.94e-11 | 275 | 43 | 10 | M5884 |
| Coexpression | NABA_BASEMENT_MEMBRANES | 5.89e-09 | 40 | 43 | 5 | M5887 | |
| Coexpression | NABA_MATRISOME | COL4A1 C1QL1 MUC19 COL4A2 COL4A3 COL4A6 COL18A1 COL24A1 COL5A3 COL7A1 COL11A1 COL11A2 | 4.99e-08 | 1008 | 43 | 12 | MM17056 |
| Coexpression | HEBERT_MATRISOME_TNBC_LUNG_METASTASIS | 5.43e-08 | 23 | 43 | 4 | M48001 | |
| Coexpression | NABA_MATRISOME | COL4A1 C1QL1 MUC19 COL4A2 COL4A3 COL4A6 COL18A1 COL24A1 COL5A3 COL7A1 COL11A1 COL11A2 | 6.06e-08 | 1026 | 43 | 12 | M5889 |
| Coexpression | GOTZMANN_EPITHELIAL_TO_MESENCHYMAL_TRANSITION_UP | 4.74e-06 | 68 | 43 | 4 | M1373 | |
| Coexpression | GOTZMANN_EPITHELIAL_TO_MESENCHYMAL_TRANSITION_UP | 5.96e-06 | 72 | 43 | 4 | MM1131 | |
| Coexpression | TIAN_TNF_SIGNALING_NOT_VIA_NFKB | 6.20e-06 | 22 | 43 | 3 | M14666 | |
| Coexpression | SWEET_KRAS_TARGETS_UP | 1.05e-05 | 83 | 43 | 4 | M2448 | |
| Coexpression | GSE17721_LPS_VS_PAM3CSK4_1H_BMDC_DN | 1.83e-05 | 199 | 43 | 5 | M3912 | |
| Coexpression | HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION | 1.87e-05 | 200 | 43 | 5 | M5930 | |
| Coexpression | WONG_ADULT_TISSUE_STEM_MODULE | 1.95e-05 | 721 | 43 | 8 | M1999 | |
| Coexpression | ROZANOV_MMP14_TARGETS_SUBSET | 2.17e-05 | 33 | 43 | 3 | M9167 | |
| Coexpression | FOROUTAN_INTEGRATED_TGFB_EMT_UP | 4.49e-05 | 120 | 43 | 4 | M42505 | |
| Coexpression | KHETCHOUMIAN_TRIM24_TARGETS_UP | 5.94e-05 | 46 | 43 | 3 | MM544 | |
| Coexpression | KHETCHOUMIAN_TRIM24_TARGETS_UP | 6.34e-05 | 47 | 43 | 3 | M1399 | |
| Coexpression | BENPORATH_ES_WITH_H3K27ME3 | 6.74e-05 | 1115 | 43 | 9 | M10371 | |
| Coexpression | BENPORATH_PRC2_TARGETS | 8.28e-05 | 650 | 43 | 7 | M8448 | |
| Coexpression | LAKE_ADULT_KIDNEY_C27_VASCULAR_SMOOTH_MUSCLE_CELLS_AND_PERICYTES | 1.21e-04 | 155 | 43 | 4 | M39246 | |
| Coexpression | HEBERT_MATRISOME_TNBC_BONE_METASTASIS | 1.43e-04 | 11 | 43 | 2 | M47997 | |
| Coexpression | ESC_V6.5_UP_EARLY.V1_DN | 1.47e-04 | 163 | 43 | 4 | M2769 | |
| Coexpression | ABBUD_LIF_SIGNALING_2_UP | 2.03e-04 | 13 | 43 | 2 | M1439 | |
| Coexpression | GU_PDEF_TARGETS_UP | 2.17e-04 | 71 | 43 | 3 | M3955 | |
| Coexpression | FOROUTAN_PRODRANK_TGFB_EMT_UP | 2.39e-04 | 185 | 43 | 4 | M42503 | |
| Coexpression | TURASHVILI_BREAST_LOBULAR_CARCINOMA_VS_LOBULAR_NORMAL_DN | 2.46e-04 | 74 | 43 | 3 | M13547 | |
| Coexpression | BRUECKNER_TARGETS_OF_MIRLET7A3_DN | 2.66e-04 | 76 | 43 | 3 | M11825 | |
| Coexpression | HEVNER_TELENCEPHALON_VASCULAR_ENDOTHELIUM_AND_MENINGEAL_CELLS | 2.72e-04 | 15 | 43 | 2 | MM402 | |
| Coexpression | FOROUTAN_TGFB_EMT_UP | 2.75e-04 | 192 | 43 | 4 | M42501 | |
| Coexpression | BENPORATH_EED_TARGETS | 2.85e-04 | 1059 | 43 | 8 | M7617 | |
| Coexpression | YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_16 | 2.98e-04 | 79 | 43 | 3 | M18400 | |
| Coexpression | YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_16 | 3.09e-04 | 80 | 43 | 3 | MM1285 | |
| Coexpression | GSE24574_NAIVE_VS_TCONV_CD4_TCELL_UP | 3.22e-04 | 200 | 43 | 4 | M8328 | |
| Coexpression | GSE43955_1H_VS_10H_ACT_CD4_TCELL_WITH_TGFB_IL6_DN | 3.22e-04 | 200 | 43 | 4 | M9675 | |
| Coexpression | GSE21546_WT_VS_ELK1_KO_ANTI_CD3_STIM_DP_THYMOCYTES_UP | 3.22e-04 | 200 | 43 | 4 | M7535 | |
| Coexpression | GSE24210_IL35_TREATED_VS_UNTREATED_TCONV_CD4_TCELL_DN | 3.22e-04 | 200 | 43 | 4 | M7850 | |
| Coexpression | NGUYEN_NOTCH1_TARGETS_DN | 3.45e-04 | 83 | 43 | 3 | M14650 | |
| Coexpression | KANG_AR_TARGETS_UP | 3.52e-04 | 17 | 43 | 2 | M2223 | |
| Coexpression | KANG_AR_TARGETS_UP | 3.52e-04 | 17 | 43 | 2 | MM1297 | |
| Coexpression | DI_MARTINO_MATRISOME_HIGHLY_PROLIFERATIVE_HNSCC_TUMOR_CELL_DERIVED | 3.52e-04 | 17 | 43 | 2 | M47995 | |
| Coexpression | KANG_IMMORTALIZED_BY_TERT_UP | 4.09e-04 | 88 | 43 | 3 | M5360 | |
| Coexpression | HUMMERICH_SKIN_CANCER_PROGRESSION_UP | 4.09e-04 | 88 | 43 | 3 | M1167 | |
| Coexpression | HUMMERICH_SKIN_CANCER_PROGRESSION_UP | 5.95e-04 | 100 | 43 | 3 | MM514 | |
| Coexpression | GROSS_HYPOXIA_VIA_ELK3_AND_HIF1A_DN | 6.67e-04 | 104 | 43 | 3 | M1318 | |
| Coexpression | HANSON_HRAS_SIGNALING_VIA_NFKB | 7.09e-04 | 24 | 43 | 2 | M1488 | |
| Coexpression | GROSS_HYPOXIA_VIA_ELK3_AND_HIF1A_DN | 7.25e-04 | 107 | 43 | 3 | MM1130 | |
| Coexpression | HANSON_HRAS_SIGNALING_VIA_NFKB | 7.70e-04 | 25 | 43 | 2 | MM644 | |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C0_RESTING_CHONDROCYTE | 8.06e-04 | 111 | 43 | 3 | M45685 | |
| CoexpressionAtlas | DevelopingKidney_e11.5_metaneph mesench_emap-3843_k-means-cluster#4_top-relative-expression-ranked_1000 | 1.80e-05 | 161 | 43 | 5 | gudmap_developingKidney_e11.5_metaneph mesench_1000_k4 | |
| ToppCell | nucseq-Mesenchymal-Myocytic|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 7.02e-10 | 194 | 43 | 7 | 2d66091097e106c7bee22e5281f50724700bdf8d | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Vascular-Mural_cell-SMC_COL|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 8.10e-10 | 198 | 43 | 7 | 8b9e8eaeffda40912a0163fdf39b93bc5e64751c | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Vascular-Mural_cell-SMC_COL-F|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 8.10e-10 | 198 | 43 | 7 | eb78b2ae6a787dbc75947e8dd5a03693285bc8be | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Vascular-Mural_cell-Pericyte-B|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.50e-08 | 171 | 43 | 6 | a4a2c5dc995589fbe3d4ca6ee1df888807e4ae34 | |
| ToppCell | tumor_Lymph_Node_/_Brain-Fibroblasts-Pericytes|tumor_Lymph_Node_/_Brain / Location, Cell class and cell subclass | 1.78e-08 | 176 | 43 | 6 | 2015539c58aa0bb118e111ffedd63dd9fe863bb1 | |
| ToppCell | cellseq2-Mesenchymal-Myocytic-Myocytic_1-Pericyte|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.84e-08 | 177 | 43 | 6 | 68263456a3c93cd195b321b309ff59e156d732fe | |
| ToppCell | cellseq2-Mesenchymal-Myocytic-Myocytic_1|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.84e-08 | 177 | 43 | 6 | e415e448c37adc102d766235e9953dec32c021f1 | |
| ToppCell | Adult-Mesenchymal-pericyte_cell|Adult / Lineage, Cell type, age group and donor | 2.55e-08 | 187 | 43 | 6 | 62759efb660179402fb574ce5701c89a2e17bcfe | |
| ToppCell | RV-01._Fibroblast_I|RV / Chamber and Cluster_Paper | 2.99e-08 | 192 | 43 | 6 | 356160b113c3305a61ceeaff33ce3c9da0be2878 | |
| ToppCell | LA-14._Fibroblast_III|World / Chamber and Cluster_Paper | 3.18e-08 | 194 | 43 | 6 | 803fa83ceada17c38ca9f933b888f7e7b0b90761 | |
| ToppCell | Bronchial-NucSeq-Stromal-Myofibroblastic-Muscle_smooth_systemic_arterial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.58e-08 | 198 | 43 | 6 | f261a37dd07976548b897af86df1d1a0dc069889 | |
| ToppCell | Tracheal-NucSeq-Stromal-Myofibroblastic-Muscle_perivascular_immune_recruiting|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.58e-08 | 198 | 43 | 6 | b7e900fc0a1b3fa5e47dcc36ce6b0c3ce6bf9739 | |
| ToppCell | Bronchial-10x5prime-Stromal-Pericyte-Muscle_pericyte_systemic|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 3.69e-08 | 199 | 43 | 6 | 78a9b26215874a46a910a4b93a51fcac1a597618 | |
| ToppCell | Parenchymal-10x5prime-Stromal-Myofibroblastic-Muscle_perivascular_immune_recruiting|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 3.80e-08 | 200 | 43 | 6 | 38190e4b32f7469df1da7d130bca6d7b12a3dd06 | |
| ToppCell | Control-Fibroblasts-Pericytes|Control / group, cell type (main and fine annotations) | 6.40e-07 | 171 | 43 | 5 | 080003f698f867935c2bfc55d241d3650f45a0ab | |
| ToppCell | Adult-Mesenchymal-pericyte_cell-D231|Adult / Lineage, Cell type, age group and donor | 6.59e-07 | 172 | 43 | 5 | 858cee96c1c06160863b4adcd7023c0d678bd50f | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5-Inh_L1-6_LAMP5_CA13_(Lamp5_Lhx6_1)|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 7.81e-07 | 178 | 43 | 5 | f332c7a96844abecf05ca057480fbea9296688a2 | |
| ToppCell | 5'-Airway_Nasal-Mesenchymal-Fibroblastic|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 8.25e-07 | 180 | 43 | 5 | 935c091bbcd6d10b81dc4731779e5bd98205c99f | |
| ToppCell | 5'-Airway_Nasal-Mesenchymal|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 8.25e-07 | 180 | 43 | 5 | 3dd384b7f3d9582b8fec9fe05100e466e6218b76 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Vascular-Mural_cell-SMC_prolif|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 8.25e-07 | 180 | 43 | 5 | 64956a85c404a2ea7e4eaf6f95ebcc52c198b7cc | |
| ToppCell | normal_Lung-Fibroblasts-Pericytes|normal_Lung / Location, Cell class and cell subclass | 8.48e-07 | 181 | 43 | 5 | f74941e49950027360d71ea3b205fc20c6929766 | |
| ToppCell | PND14-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF2|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 8.48e-07 | 181 | 43 | 5 | 3462aa1c08fbaf613b6278ab2c7a5a0940bf537d | |
| ToppCell | Pericytes-SSc-ILD_01|World / lung cells shred on cell class, cell subclass, sample id | 8.48e-07 | 181 | 43 | 5 | 35c470988a93381eefa300831aabb813fa1b90bd | |
| ToppCell | PND14-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF2-AF2_mature|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 8.48e-07 | 181 | 43 | 5 | 6730e249cac55ae892cc567d9211615882f3dab4 | |
| ToppCell | droplet-Kidney-KIDNEY-1m-Epithelial-kidney_collecting_duct_principal_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.71e-07 | 182 | 43 | 5 | 2ef6889321fd0104d277518d130e19143b3af41c | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5-Inh_L5-6_LAMP5_SFTA3_(Lamp5_Lhx6_2)|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 8.95e-07 | 183 | 43 | 5 | f8b636391f752e379a5c5575fd898bdf0907a3b8 | |
| ToppCell | tumor_Lung-Fibroblasts-Pericytes|tumor_Lung / Location, Cell class and cell subclass | 8.95e-07 | 183 | 43 | 5 | a03dd563af9b15cb1f5de5732a229405a9f82d84 | |
| ToppCell | 5'-Airway_Nasal-Mesenchymal-Fibroblastic-fibroblastic_type_2|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 8.95e-07 | 183 | 43 | 5 | 803376f5260de83c48d4f7301278d078a32b3e6e | |
| ToppCell | 5'-Airway_Nasal-Mesenchymal-Fibroblastic-fibroblastic_type_2-Peribronchial_fibroblasts-Peribronchial_fibroblasts_L.2.1.3.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 8.95e-07 | 183 | 43 | 5 | 6d98973098c6d20c5305bce6a83a549a7d8dbfba | |
| ToppCell | 5'-Airway_Nasal-Mesenchymal-Fibroblastic-fibroblastic_type_2-Peribronchial_fibroblasts|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 8.95e-07 | 183 | 43 | 5 | cc7f5a17b40e8d901885174922e5fa8877643071 | |
| ToppCell | Adult-Mesenchymal-pericyte_cell-D122|Adult / Lineage, Cell type, age group and donor | 8.95e-07 | 183 | 43 | 5 | fc31a43a637423cb3bb9aa184a3a889a0b9aaea6 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5-Inh_L1-6_LAMP5_CA13_(Lamp5_Lhx6_1)|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 9.19e-07 | 184 | 43 | 5 | ae0a77e3e520a246b17776bb19503519636b02ee | |
| ToppCell | COVID-19-Fibroblasts-Pericytes|COVID-19 / group, cell type (main and fine annotations) | 9.44e-07 | 185 | 43 | 5 | 4905adaeeffd353e089578e5ea614437dbe794e6 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5-Inh_L1-6_LAMP5_CA13_(Lamp5_Lhx6_1)|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 9.70e-07 | 186 | 43 | 5 | 77592a6397b44b2b59a4fc39d7224dd95343efe6 | |
| ToppCell | COPD-Stromal-Pericyte|World / Disease state, Lineage and Cell class | 9.70e-07 | 186 | 43 | 5 | 8adfd2d1fda4e8aecc95192ea627bf7ed5214b8d | |
| ToppCell | (2)_Fibroblasts-(20)_Fibro-1|(2)_Fibroblasts / Cell class and subclass of bone marrow stroma cells in homeostatis | 9.70e-07 | 186 | 43 | 5 | e93415b59dd89bc8a966dab0e0b65fe215933598 | |
| ToppCell | 5'-GW_trimst-1.5-LargeIntestine-Mesenchymal-Pericytes-Immature_pericyte|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 9.96e-07 | 187 | 43 | 5 | 6820bfbe552ea5e62cfe699687b051a17d9fda61 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5-Inh_L5-6_LAMP5_SFTA3_(Lamp5_Lhx6_2)|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.02e-06 | 188 | 43 | 5 | 8268574584e5fb869a6cb8bbd7135cd7454a6a25 | |
| ToppCell | Pericytes-SSc-ILD_02|World / lung cells shred on cell class, cell subclass, sample id | 1.02e-06 | 188 | 43 | 5 | f16ff998393bf1954bbf10caab15173bdb104ac1 | |
| ToppCell | facs-Brain_Non-Myeloid-Hippocampus_-18m-Macroglial-oligodendrocyte_precursor_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.02e-06 | 188 | 43 | 5 | 006db2c2c44971ca9241c582bc89f258c785f5ed | |
| ToppCell | facs-Brain_Non-Myeloid-Hippocampus_-18m-Macroglial-Oligodendrocyte_progenitor_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.02e-06 | 188 | 43 | 5 | d0e6fb4a3b3d79d3512b5500062ea285495ae526 | |
| ToppCell | Pericytes-IPF_03|World / lung cells shred on cell class, cell subclass, sample id | 1.02e-06 | 188 | 43 | 5 | 14c1c88a944c66f2eaac1ce7526815dcce1f5147 | |
| ToppCell | LV-14._Fibroblast_III|World / Chamber and Cluster_Paper | 1.05e-06 | 189 | 43 | 5 | 3922135d1f6fc768d71ba3b465585fead6ea68a8 | |
| ToppCell | tumor_Lung-Fibroblasts-Pericytes|Fibroblasts / Location, Cell class and cell subclass | 1.05e-06 | 189 | 43 | 5 | 9c407b17d7945e81e1ae6c18452f5d20fb09d563 | |
| ToppCell | tumor_Lymph_Node_/_Brain-Fibroblasts-Pericytes|Fibroblasts / Location, Cell class and cell subclass | 1.05e-06 | 189 | 43 | 5 | f4865b7db16de15120504147a8016ac522ad242a | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5-Inh_L1-6_LAMP5_CA13_(Lamp5_Lhx6_1)|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.08e-06 | 190 | 43 | 5 | 2f54da2bee411f8868348a4c37034184b8f58a89 | |
| ToppCell | nucseq-Mesenchymal-Myocytic-Myocytic_1-Pericyte|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.08e-06 | 190 | 43 | 5 | 4eb92aef1ee868f4537483d19014d947b7684612 | |
| ToppCell | 3'-Child09-12-SmallIntestine-Mesenchymal-Pericytes-Pericyte|Child09-12 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.08e-06 | 190 | 43 | 5 | 136ca6da77a202874376af193a1dd71d810c76c4 | |
| ToppCell | LV-01._Fibroblast_I|World / Chamber and Cluster_Paper | 1.08e-06 | 190 | 43 | 5 | 12992ec80a7b4f4f17de693f0719ee061a9918fd | |
| ToppCell | nucseq-Mesenchymal-Myocytic-Myocytic_1|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.08e-06 | 190 | 43 | 5 | 7be4341e2909101d756f14031c21e705eb45e69a | |
| ToppCell | RV-01._Fibroblast_I|World / Chamber and Cluster_Paper | 1.10e-06 | 191 | 43 | 5 | 70c067c54084bfb02c29bab085f4defd477194fb | |
| ToppCell | LA-14._Fibroblast_III|LA / Chamber and Cluster_Paper | 1.16e-06 | 193 | 43 | 5 | 7426c291bac59e539c427bcaae18abc7d397d44e | |
| ToppCell | LV-01._Fibroblast_I|LV / Chamber and Cluster_Paper | 1.16e-06 | 193 | 43 | 5 | dc17f3b9758936d428cf17f77a1ce6d4c479b165 | |
| ToppCell | LV-14._Fibroblast_III|LV / Chamber and Cluster_Paper | 1.19e-06 | 194 | 43 | 5 | 927c26aea0147f7a4b8fb3f192de4de263f1b978 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Vascular-Mural_cell-SMC_prolif-G|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.19e-06 | 194 | 43 | 5 | 78dcb9d48259afabe73b41c5508a73a8d62339a4 | |
| ToppCell | IPF-Stromal-Pericyte|World / Disease state, Lineage and Cell class | 1.19e-06 | 194 | 43 | 5 | 1a41da29d5adaf766a84eff0003b959e4523f7f1 | |
| ToppCell | TCGA-Head_and_Esophagus-Primary_Tumor-Head_and_Neck_Carcinoma-Squamous_Cell_Carcinoma-8|TCGA-Head_and_Esophagus / Sample_Type by Project: Shred V9 | 1.19e-06 | 194 | 43 | 5 | 55b97095a7a17a312c616703d291738a0f806339 | |
| ToppCell | COVID-19-lung-Pericytes/_Smooth_Muscle|lung / Disease (COVID-19 only), tissue and cell type | 1.19e-06 | 194 | 43 | 5 | 5e1e0513a54ec4cf0b247ec85c9fbc68dfac1da3 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Vascular-Mural_cell-SMC_COL-D|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.22e-06 | 195 | 43 | 5 | 78cfde21dde4b877fc76c8b0d5ddaabe44b912d7 | |
| ToppCell | RA-02._Fibroblast_II|RA / Chamber and Cluster_Paper | 1.22e-06 | 195 | 43 | 5 | 6a02ebbeb3199447ddce64d92d8809436e040eba | |
| ToppCell | IPF-Stromal-Pericyte|IPF / Disease state, Lineage and Cell class | 1.25e-06 | 196 | 43 | 5 | 8b6ff47ce5291d223f5e639fc45cd9267f418256 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Vascular-Mural_cell-Pericyte-C|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.25e-06 | 196 | 43 | 5 | 12d9028f90c057c6e5cff00301793fa550e86c5a | |
| ToppCell | 5'-Adult-Appendix|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.25e-06 | 196 | 43 | 5 | a579211ef14f348d0c5a290553150222dfbf1515 | |
| ToppCell | metastatic_Lymph_Node-Fibroblasts|metastatic_Lymph_Node / Location, Cell class and cell subclass | 1.25e-06 | 196 | 43 | 5 | 275e153347caf94edc0c50021bbab49c8696fecb | |
| ToppCell | Bronchial-NucSeq-Stromal-Myofibroblastic-Muscle_perivascular_immune_recruiting|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.29e-06 | 197 | 43 | 5 | cfb3dc4b401800e33c82cfc3baee69dbbd16ac8c | |
| ToppCell | Parenchymal-NucSeq-Stromal-Pericyte-Muscle_pericyte_pulmonary|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.29e-06 | 197 | 43 | 5 | f66945f9007d59d4208849c7fd727f8519713fbc | |
| ToppCell | Non-neuronal-Non-dividing-Radial_Glia-tRG|World / Primary Cells by Cluster | 1.29e-06 | 197 | 43 | 5 | 61749ccafeb938c310cff1de5ff924a1c794325a | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Mesenchymal-Pericytes|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.29e-06 | 197 | 43 | 5 | 1c91e3afcc5be195b827a1dff83aff5cc2492456 | |
| ToppCell | Parenchymal-NucSeq-Stromal-Pericyte|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.29e-06 | 197 | 43 | 5 | 41dd312f46a2b983c8d864adeb6970c0ca4a8048 | |
| ToppCell | Non-neuronal-Non-dividing-Radial_Glia-tRG-25|World / Primary Cells by Cluster | 1.29e-06 | 197 | 43 | 5 | 9d4ffa3680f92c91d0a081f9a8ec5ebfec6bdcf6 | |
| ToppCell | wk_20-22-Mesenchymal-Myofibro_&_SMC-Pericyte|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 1.29e-06 | 197 | 43 | 5 | 44cd1ece3633a31e8c9b667cd3cbc2749c06f478 | |
| ToppCell | Bronchial-NucSeq-Stromal-Peri/Epineurial_|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.29e-06 | 197 | 43 | 5 | ee8f7def9d5af7b1e636830a4ea1da158d02f25a | |
| ToppCell | Tracheal-NucSeq-Stromal-Myofibroblastic-Muscle_smooth_systemic_arterial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.32e-06 | 198 | 43 | 5 | 7dd874b09c81cc512ccc1e9b65f290a5f94d736e | |
| ToppCell | Bronchial-10x5prime-Stromal-Myofibroblastic-Muscle_perivascular_immune_recruiting|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.32e-06 | 198 | 43 | 5 | dc6d9032c5029527e184ac13b887c0c1f22ef1c0 | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-1m-Mesenchymal|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.32e-06 | 198 | 43 | 5 | b086af292a508a156266c2d899ba1caf820bf61c | |
| ToppCell | Parenchymal-10x5prime-Stromal-Pericyte-Muscle_pericyte_systemic|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.32e-06 | 198 | 43 | 5 | 0dc5806714fb3d3983e9d19fa7a108e93a8090ed | |
| ToppCell | metastatic_Brain-Fibroblasts|metastatic_Brain / Location, Cell class and cell subclass | 1.35e-06 | 199 | 43 | 5 | 63eb2106bb6e2e33d020628583536c8d96662c84 | |
| ToppCell | 3'-Child04-06-SmallIntestine-Mesenchymal-Pericytes-Pericyte|Child04-06 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.35e-06 | 199 | 43 | 5 | bd9b36dcf61eaa628ce1b70d21c5783b64c29e8f | |
| ToppCell | Brain_organoid-organoid_Paulsen_bioRxiv-1_mon-Proliferating-Cycling_Progenitors|1_mon / Sample Type, Dataset, Time_group, and Cell type. | 1.35e-06 | 199 | 43 | 5 | 358c4b3037f59378db8916a2fbe9ed4830cf1449 | |
| ToppCell | 3'-Child04-06-SmallIntestine-Mesenchymal-Pericytes|Child04-06 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.35e-06 | 199 | 43 | 5 | e751eb67510f8a5842dcfed44134160919cdb713 | |
| ToppCell | Neuronal-Inhibitory-iA-iA_2(LAMP5)-CA1-|Neuronal / cells hierarchy compared to all cells using T-Statistic | 1.39e-06 | 200 | 43 | 5 | ca5401b76ab014080914bf78042d368cf318effa | |
| ToppCell | cellseq2-Mesenchymal|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.39e-06 | 200 | 43 | 5 | 6b558cce0d6047c7e85f428adff80c5ca3084ea4 | |
| ToppCell | Bronchial-NucSeq-Stromal-Myofibroblastic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.39e-06 | 200 | 43 | 5 | a66449b22b39dd6987fc2c3ed160d24564234ced | |
| ToppCell | Tracheal-10x3prime_v2-Stromal-Pericyte-Muscle_pericyte_pulmonary|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 1.39e-06 | 200 | 43 | 5 | 8158f4eaeff945a6788c8e732b7a1b0d78052a06 | |
| ToppCell | Biopsy_Other_PF-Mesenchymal-Smooth_Muscle_cells|Biopsy_Other_PF / Sample group, Lineage and Cell type | 1.39e-06 | 200 | 43 | 5 | 55ac281901309e30978da1f7489386e54489721e | |
| ToppCell | Parenchyma_COVID-19-Stromal-TX-Smooth_muscle-1|Parenchyma_COVID-19 / Sample group, Lineage and Cell type | 1.39e-06 | 200 | 43 | 5 | 78e9a40153d7ba5d9ea6393a37d26fc5c0220867 | |
| ToppCell | Neuronal-Inhibitory-iA-iA_2(LAMP5)-CA1--L2-6|Neuronal / cells hierarchy compared to all cells using T-Statistic | 1.39e-06 | 200 | 43 | 5 | 70c47d3bbe67d88c5b9dff99c33a603d25fa2ab0 | |
| ToppCell | Lung_Parenchyma-Severe-Mesenchymal-Mesenchymal-Smooth_muscle-1|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.39e-06 | 200 | 43 | 5 | c46e06b4f22d3456e67bc62a9ac198e8041965ad | |
| ToppCell | Neuronal-Inhibitory-iA-iA_2(LAMP5)-CA1|Neuronal / cells hierarchy compared to all cells using T-Statistic | 1.39e-06 | 200 | 43 | 5 | 40286010bd17cf9e34ecd5440953b072ebfae208 | |
| ToppCell | Lung_Parenchyma-Severe-Mesenchymal-Mesenchymal-Smooth_muscle-1-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.39e-06 | 200 | 43 | 5 | 43b76e382b38b9856c07557a75e5b1ce0cee1d9e | |
| ToppCell | Tracheal-NucSeq-Stromal-Pericyte-Muscle_pericyte_systemic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.39e-06 | 200 | 43 | 5 | 9d3ae9ea47b1017adb63aa02d10e98193d478458 | |
| ToppCell | Tracheal-NucSeq-Stromal-Pericyte|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.39e-06 | 200 | 43 | 5 | 78cd0b7d221ef855512ee9ac9a291f61622c2e24 | |
| ToppCell | Frontal_cortex-Endothelial-ENDOTHELIAL_TIP-Dcn_1-Dcn_1_1-Endothelial_Tip.Dcn.Inmt_(Inmt)|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 5.66e-06 | 121 | 43 | 4 | 5035e071033cb76a7fc0128716755b14821e8f05 | |
| ToppCell | Frontal_cortex-Endothelial-ENDOTHELIAL_TIP-Dcn_1-Dcn_1_1-Endothelial_Tip.Dcn.Inmt_(Inmt)-|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 5.66e-06 | 121 | 43 | 4 | c96115bd33455296378a257583b49442d00b39ca | |
| ToppCell | frontal_cortex-Non-neuronal-oligodendrocyte-Oligo-OPC_Pdgfra_Grm5|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 8.24e-06 | 133 | 43 | 4 | 63d2f096ae47d9b587acc6c5fbd346e5e58842b8 | |
| ToppCell | Hippocampus-Endothelial-ENDOTHELIAL_TIP-Dcn_1-Dcn_1_1|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 8.48e-06 | 134 | 43 | 4 | b959899c89d3a0363a3cd2309155280e0fe5ba88 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Vascular-Mural_cell-SMC-G|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.26e-05 | 148 | 43 | 4 | e514b7cf412ddbee249894e089e2204c67bcdbce | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Glial-Neuronal-OPC-OPC-E|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.51e-05 | 155 | 43 | 4 | 77fdae85d36efb776db977eb424b32487ef222e4 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Vascular-Mural_cell-SMC_prolif-A|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.62e-05 | 158 | 43 | 4 | 32c95c1bc9e50fccd6d06e828f29258fc5e568cb | |
| ToppCell | Transplant_Alveoli_and_parenchyma-Epithelial-Type_1_alveolar|Epithelial / Tissue, Lineage and Cell class of Lung Cells from 10X | 1.71e-05 | 160 | 43 | 4 | 58ed3a074932ccc951e07868dfdc61b99ae1cc2b | |
| Computational | Genes upregulated in subsets of cells of a given type within various tumors | 1.33e-07 | 50 | 27 | 5 | GAVISH_3CA_METAPROGRAM_FIBROBLASTS_CAF_2 | |
| Computational | Genes upregulated in subsets of cells of a given type within various tumors | 2.56e-04 | 50 | 27 | 3 | GAVISH_3CA_METAPROGRAM_FIBROBLASTS_PERICYTE_LIKE | |
| Computational | Adhesion molecules. | 3.94e-04 | 141 | 27 | 4 | MODULE_122 | |
| Drug | GK-101 | 2.36e-15 | 36 | 43 | 8 | CID000161853 | |
| Drug | Madecassol | 2.01e-14 | 46 | 43 | 8 | CID000108062 | |
| Drug | d-indobufen | 4.11e-14 | 50 | 43 | 8 | CID000044562 | |
| Drug | DMSe | COL4A1 COL4A3 TPRX1 COL4A6 COL18A1 COL24A1 COL5A3 COL7A1 COL11A1 COL11A2 | 4.95e-14 | 132 | 43 | 10 | CID000020796 |
| Drug | ridogrel | 5.74e-14 | 52 | 43 | 8 | CID005362391 | |
| Drug | NSC49633 | 6.76e-14 | 53 | 43 | 8 | CID000023340 | |
| Drug | AC1LAKND | 2.55e-13 | 62 | 43 | 8 | CID000470146 | |
| Drug | PPACK | COL4A1 WDR81 COL4A3 COL4A6 COL18A1 COL24A1 COL7A1 COL11A1 COL11A2 | 6.47e-13 | 113 | 43 | 9 | CID003036757 |
| Drug | BAPN | 7.91e-13 | 71 | 43 | 8 | CID000001647 | |
| Drug | malotilate | 7.91e-13 | 71 | 43 | 8 | CID000004006 | |
| Drug | AC1NMZ1B | 1.25e-12 | 75 | 43 | 8 | CID005034185 | |
| Drug | strontium ranelate | 1.55e-12 | 77 | 43 | 8 | CID006918182 | |
| Drug | halofuginone lactate | 3.51e-12 | 85 | 43 | 8 | CID000062891 | |
| Drug | 4-hydroxyproline | 6.15e-12 | 91 | 43 | 8 | CID000000825 | |
| Drug | ticlopidine | 1.69e-11 | 103 | 43 | 8 | CID000005472 | |
| Drug | hydroxylysine | 2.68e-11 | 109 | 43 | 8 | CID000001029 | |
| Drug | AC1L1C2F | 2.89e-11 | 110 | 43 | 8 | CID000001711 | |
| Drug | AC1L9732 | 3.86e-11 | 114 | 43 | 8 | CID000439300 | |
| Drug | Tranilast sodium | 4.14e-11 | 115 | 43 | 8 | CID000005527 | |
| Drug | foscarnet | COL4A1 COL4A3 COL4A6 COL18A1 COL24A1 COL7A1 COL11A1 COL11A2 BSN | 7.16e-11 | 190 | 43 | 9 | CID000003414 |
| Drug | Selara | 8.12e-11 | 125 | 43 | 8 | CID000150310 | |
| Drug | pirfenidone | 1.80e-10 | 138 | 43 | 8 | CID000040632 | |
| Drug | DL-penicillamine | 1.91e-10 | 139 | 43 | 8 | CID000004727 | |
| Drug | PCR 4099 | 1.91e-10 | 139 | 43 | 8 | CID000002806 | |
| Drug | candesartan cilexetil | 2.68e-10 | 145 | 43 | 8 | CID000002540 | |
| Drug | L-lysyl-L-lysyl-L-lysine | 6.48e-10 | 162 | 43 | 8 | CID000072363 | |
| Drug | prostacyclin sodium salt | COL4A1 WDR81 COL4A3 COL4A6 COL18A1 COL24A1 COL7A1 COL11A1 COL11A2 | 8.18e-10 | 250 | 43 | 9 | CID000000159 |
| Drug | khellin | 9.96e-10 | 171 | 43 | 8 | CID000003828 | |
| Drug | AC1L1DD6 | 1.43e-09 | 179 | 43 | 8 | CID000002299 | |
| Drug | 12(S)-hydroxyeicosatetraenoic acid | 2.20e-09 | 189 | 43 | 8 | CID000001413 | |
| Drug | AC1Q6PCP | 1.03e-08 | 230 | 43 | 8 | CID000005267 | |
| Drug | hyaluronan | 2.91e-08 | 263 | 43 | 8 | CID000024759 | |
| Drug | colchine | COL4A1 COL4A3 COL4A6 COL18A1 COL24A1 COL7A1 COL11A1 COL11A2 BSN | 3.34e-08 | 383 | 43 | 9 | CID000002833 |
| Drug | silibinin | 5.42e-08 | 285 | 43 | 8 | CID000005213 | |
| Drug | aspirin | COL4A1 COL4A3 COL4A6 COL18A1 COL24A1 COL7A1 COL11A1 COL11A2 GSK3A TBX21 | 7.26e-08 | 563 | 43 | 10 | CID000002244 |
| Drug | (2s,5s)-5-Carboxymethylproline | 1.14e-07 | 314 | 43 | 8 | CID000447989 | |
| Drug | Y-27632 | COL4A1 COL4A3 COL4A6 COL18A1 COL24A1 COL7A1 COL11A1 COL11A2 GSK3A | 1.18e-07 | 444 | 43 | 9 | CID000005711 |
| Drug | AC1L18QD | 1.48e-07 | 325 | 43 | 8 | CID000000213 | |
| Drug | losartan | 4.68e-07 | 378 | 43 | 8 | CID000003961 | |
| Drug | chondroitin sulfate | 9.11e-07 | 413 | 43 | 8 | CID000024766 | |
| Drug | Pseudopelletierine hydrochloride [6164-62-1]; Down 200; 21uM; PC3; HT_HG-U133A | 1.98e-06 | 200 | 43 | 6 | 5828_DN | |
| Drug | AC1L1KMJ | 2.62e-06 | 476 | 43 | 8 | CID000030956 | |
| Drug | LMWH | COL4A1 WDR81 COL4A3 COL4A6 COL18A1 COL24A1 COL7A1 COL11A1 COL11A2 | 3.32e-06 | 663 | 43 | 9 | CID000000772 |
| Drug | Naringenine [480-41-1]; Down 200; 14.6uM; MCF7; HT_HG-U133A | 3.16e-05 | 194 | 43 | 5 | 4422_DN | |
| Drug | Cefmetazole sodium salt [56796-39-5]; Down 200; 8.2uM; PC3; HT_HG-U133A | 3.32e-05 | 196 | 43 | 5 | 5868_DN | |
| Drug | PbCl2 | 7.87e-05 | 44 | 43 | 3 | CID000024459 | |
| Drug | LS-63783 | 1.13e-04 | 804 | 43 | 8 | CID000000231 | |
| Drug | cyclophorine | 1.41e-04 | 426 | 43 | 6 | CID000002909 | |
| Drug | genkwanin | 1.55e-04 | 10 | 43 | 2 | CID005281617 | |
| Drug | Digoxigenin [1672-46-4]; Up 200; 10.2uM; PC3; HT_HG-U133A | 2.95e-04 | 170 | 43 | 4 | 4680_UP | |
| Disease | collagen disease (implicated_via_orthology) | 6.28e-07 | 12 | 43 | 3 | DOID:854 (implicated_via_orthology) | |
| Disease | myopathy (implicated_via_orthology) | 7.26e-07 | 48 | 43 | 4 | DOID:423 (implicated_via_orthology) | |
| Disease | Fibrochondrogenesis | 2.07e-06 | 2 | 43 | 2 | C0265282 | |
| Disease | Developmental Porencephaly | 2.07e-06 | 2 | 43 | 2 | C4082301 | |
| Disease | Post-traumatic Porencephaly | 2.07e-06 | 2 | 43 | 2 | C3698507 | |
| Disease | Congenital porencephaly | 2.07e-06 | 2 | 43 | 2 | C0302892 | |
| Disease | Porencephaly | 2.07e-06 | 2 | 43 | 2 | C4082173 | |
| Disease | PORENCEPHALY, FAMILIAL | 2.07e-06 | 2 | 43 | 2 | C1867983 | |
| Disease | HEMORRHAGE, INTRACEREBRAL, SUSCEPTIBILITY TO | 2.07e-06 | 2 | 43 | 2 | C3281105 | |
| Disease | Porencephaly, Type 1, Autosomal Dominant | 2.07e-06 | 2 | 43 | 2 | C4551998 | |
| Disease | Stickler syndrome (implicated_via_orthology) | 2.07e-06 | 2 | 43 | 2 | DOID:0080046 (implicated_via_orthology) | |
| Disease | Hemorrhage, intracerebral, susceptibility to | 6.22e-06 | 3 | 43 | 2 | cv:C3281105 | |
| Disease | HEMORRHAGE, INTRACEREBRAL, SUSCEPTIBILITY TO | 6.22e-06 | 3 | 43 | 2 | 614519 | |
| Disease | Stickler syndrome | 2.07e-05 | 5 | 43 | 2 | cv:C0265253 | |
| Disease | Cartilage Diseases | 3.10e-05 | 6 | 43 | 2 | C0007302 | |
| Disease | Chondromalacia | 3.10e-05 | 6 | 43 | 2 | C0085700 | |
| Disease | Familial thoracic aortic aneurysm and aortic dissection | 6.42e-05 | 53 | 43 | 3 | C4707243 | |
| Disease | Connective Tissue Diseases | 1.60e-04 | 13 | 43 | 2 | C0009782 | |
| Disease | Acute myeloid leukemia | 2.78e-04 | 17 | 43 | 2 | cv:C0023467 | |
| Disease | LEUKEMIA, ACUTE MYELOID | 2.78e-04 | 17 | 43 | 2 | 601626 | |
| Disease | waist-hip ratio | 3.44e-04 | 1226 | 43 | 8 | EFO_0004343 | |
| Disease | glomerular filtration rate, renal transplant outcome measurement, donor genotype effect measurement | 4.70e-04 | 22 | 43 | 2 | EFO_0005199, EFO_0005208, EFO_0007892 | |
| Disease | Nephrotic Syndrome | 7.11e-04 | 27 | 43 | 2 | C0027726 | |
| Disease | Cerebral Hemorrhage | 7.65e-04 | 28 | 43 | 2 | C2937358 | |
| Disease | spontaneous coronary artery dissection | 9.39e-04 | 31 | 43 | 2 | EFO_0010820 | |
| Disease | Hereditary hearing loss and deafness | 1.27e-03 | 146 | 43 | 3 | cv:C0236038 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| SVPGSVPGVLGPTGG | 291 | Q99626 | |
| GISGPPGFPGLGTTG | 271 | Q14031 | |
| GSYGPSGFPGTPGFP | 661 | Q14031 | |
| SGLPGFSGSPGLPGT | 96 | Q01955 | |
| FSGSPGLPGTPGNTG | 101 | Q01955 | |
| GPPGPSGLPGESYGS | 271 | Q01955 | |
| GSPGSPGNTGLPGFP | 511 | Q01955 | |
| GPPGLPGAGGSGAIS | 106 | O75973 | |
| TGFPGLTGPPGSQGE | 1151 | P08572 | |
| GVPGSPGFLNGSPTG | 491 | Q9HAK2 | |
| PSVPGSGGPPAGGSG | 376 | Q96EP5 | |
| GPPGGVGFPGSRGDT | 586 | P02462 | |
| SPGSVGYPGSPGLPG | 1101 | P02462 | |
| VGFPGLAGSPGIPGS | 1191 | P02462 | |
| GPPGFGSGPPGLGSA | 801 | Q9NTZ6 | |
| GSFPGGRFGSPSPGG | 71 | Q8TAP9 | |
| GVLGSGGGPPRGPGF | 486 | Q16538 | |
| GAAGGPGSRPPGGSY | 1401 | Q5JU85 | |
| PVGTGTAPGGGPGSG | 1116 | Q96Q04 | |
| GPGSGPGALPKTGGT | 421 | Q9UPA5 | |
| LTGRPGPVGGPGSSG | 536 | P12107 | |
| PGTPGTPGGATSGGK | 2001 | Q7Z5P9 | |
| PGGSGTTRAGPPGGT | 7346 | Q7Z5P9 | |
| EPGGGGFFGSSLPGP | 1341 | P39060 | |
| GGPGGGGAPPRYATL | 181 | Q14332 | |
| FPGERGLPGTAGGPG | 986 | P13942 | |
| FGSPPTFGGSPGFGG | 1976 | P35658 | |
| PGYSTGGGGGPQPLR | 116 | Q9BRQ0 | |
| AGGPGGPLSVYPGAG | 131 | P23769 | |
| PGGPGGPGFASTDIS | 291 | Q8WXS5 | |
| GSGGPGAGTSFPPPG | 76 | P49840 | |
| GERGTPGIGGFPGPS | 2701 | Q02388 | |
| VGVGPGTGGSPGPSA | 16 | Q9BX70 | |
| GSVFPAGGGPLLTGG | 56 | Q9H329 | |
| RLSPPGGSGSGVPGG | 711 | Q8NFZ4 | |
| GGSGSGVPGGGPLLP | 716 | Q8NFZ4 | |
| GPTGSEGTPGLPGGV | 1181 | P25940 | |
| GGTLGGGTLGPPSPP | 236 | Q06587 | |
| SSPGTYVGPPGGGGP | 261 | Q9BWW4 | |
| GSGGAGGPPGTPYEL | 676 | Q9ULL5 | |
| GAAPGRGTPPSYGGG | 291 | O75526 | |
| GPGATGIGTPAAGPG | 351 | P08913 | |
| GSPGLVGGTGPPGFP | 666 | Q17RW2 | |
| VGGTGPPGFPGLRGS | 671 | Q17RW2 | |
| GLAPILGPGSGPGSG | 301 | Q8N7U7 | |
| RGAGTGTGLGGPGTP | 16 | Q9P1D8 | |
| PTPGVGSLLGGPGGT | 1266 | Q96JG9 | |
| FLLPSGPGPTSGGGG | 326 | Q96C00 | |
| GGPTSLGGGAGGPLL | 101 | Q96DT7 | |
| GPPGSGTPSRGGRSG | 1296 | Q9C0J8 | |
| GGSLGSPYPGGALVP | 51 | Q9UL17 | |
| PLGPISGVGGGGLGS | 1581 | Q562E7 | |
| ATGGPPAGPGGVYAG | 161 | P17275 |